Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Januar 2023 09:00 ET | Quelle: Visiongain Reports Ltd

Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
28. November 2022 12:08 ET | Quelle: Visiongain Reports Ltd

Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
07. April 2022 09:00 ET | Quelle: Visiongain Ltd

Global Macular Degeneration (AMD) and other retinal diseases drugs market is projected to reach at a market value of US$ 40.16 Billion by 2031: Visiongain Research Inc

Visiongain has published a global macular degeneration (AMD) and other retinal diseases drugs market report 2021-2031.Forecasts By Indication (diabetic macular edema, diabetic retinopathy, retinal...